GENE ONLINE|News &
Opinion
Blog

2022-04-06| Asia-PacificStartups

SeaX Ventures on $60 Million Journey to Aid Startups in Southeast Asia

by Joy Lin
Share To

Southeast Asia Exponential Ventures, also known as SeaX Ventures, wants to help accelerate the growth of emerging global startups across Southeast Asia. And now it has $60 million to help companies across blockchain and web3, foodtech, biotech and life science, artificial intelligence, robotics, and IoT and hardware. 

Originally, the venture capital firm aimed to raise $50 million for its second fund, but hit $60 million after funding was oversubscribed. According to SeaX, the company will invest between $500,000 to $5 million in pre-seed, seed, and Series A financings. 

With a regional population of 650 million people and a combined GDP of $3 trillion, the SEA region offers a ripe location for international startups to develop. 

“We can help innovative startups from across the world grow exponentially in this large and dynamic area through our relationship with over 400 corporates,” said Dr. Supachai “Kid” Parchariyanon, the Founder and Managing Partner of SeaX Ventures.

 

RISE with SeaX

 

SeaX is not Dr. Kid’s only venture. He also founded RISE, a corporate innovation consulting firm that helps larger SEA companies in the digital realm. SeaX helps its portfolio companies expand by connecting them with investors and RISE clients. This also helps larger companies discover innovative initiatives, launch new businesses, or reduce operating costs. 

SeaX’s Limited Partners include PTT OR International Holdings (Singapore) Pte. Ltd., Central Pattana PCL, Singha Ventures Corporation, Ramkhamhaeng Hospital PCL, MC Group PCL, The Vacharaphol Co., Ltd. (Thairath News), T.K.S. Technologies PCL, Modernform PCL, and BCH Ventures, among others.

Despite only raising two funds since its founding in the US in 2018, SeaX has already invested in the seeding rounds of three unicorns. The company has invested in startups including AiFi, Apollo Neuroscience, Bot MD, Solana, and Qvin. Its most recent investment was in the $65 million Series B round of AiFi. 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
Pearl Bio Enters $1 Billion Partnership Agreement with MSD for Biologic Therapies
2024-03-13
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top